| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |